ArticleVaccines2021

Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study.

Cinzia Rotondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.